ライフサイエンスコーパス: GABA(A) receptor agonist

1 by reducing levels of methylglyoxal (MG), a GABAA receptor agonist.

2 unit gamma2 (TAT-GABAgamma2) and muscimol, a GABAA receptor agonist.

3 ying 2 mum glycine or 0.1 mum isoguvacine, a GABAA-receptor agonist.

4 ecting brain-state switching when exposed to GABAA-receptor agonists.

5 was prevented by coinjection to the VMH of a GABA(A) receptor agonist.

6 ical properties of natural ALLO but is not a GABA(A) receptor agonist.

7 r phenotype in C57BL/6J mice by infusing the GABAA receptor agonist, 4,5,6,7-tetrahydroisoxazolo-[5,4

8 In addition, GABA(A) receptor agonists activated a tonic current in R

9 s can be suppressed by microinjection of the GABA(A) receptor agonist and neuronal inhibitor muscimol

10 to compare binding and unbinding kinetics of GABA(A) receptor agonists and antagonists in outside-out

11 Muscimol, a GABA(A) receptor agonist at a dose of 5 ng, injected int

12 o target recordings from SACs, we found that GABA(A) receptor agonists blocked compound postsynaptic

13 Lorazepam, a GABA(A) receptor agonist, blocked this increased excitab

14 or antagonist, bicuculline (3-30 ng), or the GABA(A) receptor agonists, chlordiazepoxide, a benzodiaz

15 Neither GABA(A) receptor agonist elevated aggression, which coul

16 A GABAA receptor agonist, Glu receptor antagonists, or a G

17 oxypyrazole (4-AHP) analogues of muscimol, a GABA(A) receptor agonist, has been synthesized and pharm

18 glutamate receptor antagonist) and muscimol (GABAA receptor agonist) in the SubC virtually eliminated

19 orms in lethargus show partial resistance to GABA(A) receptor agonists, indicating that postsynaptic

20 n rats by microinjection of small amounts of GABAA-receptor agonists into an upper brainstem region n

21 ion was disrupted by infusion of muscimol, a GABA(A) receptor agonist, into the DH.

22 In experiment 1, infusion of muscimol, a GABAA receptor agonist, into the dorsal hippocampus befo

23 Pretraining infusions of muscimol, a GABAA receptor agonist, into the VH disrupted auditory,

24 ynaptic responsiveness to local puffs of the GABAA receptor agonist isoguvacine.

25 id and 6-cyano-7-nitro-quinoxalone) and by a GABAA receptor agonist (isoguvacine) when these agents w

26 Control experiments using a GABAA receptor agonist, isoguvacine, indicated that both

27 ted with artificial extracellular fluid, the GABA(A) receptor agonist muscimol (1 nmol/side), or the

28 assessed before, and after, injection of the GABA(A) receptor agonist muscimol 80 pmol (100 nl)(-1) o

29 Bath application of the GABA(A) receptor agonist muscimol blocked spontaneous co

30 In intact cells, GABA and the GABA(A) receptor agonist muscimol caused a rapid and tra

31 ansition, but not the Vc/C1 junction, by the GABA(A) receptor agonist muscimol inhibited CO2-evoked t

32 The GABA(A) receptor agonist muscimol inhibited learning in

33 ient inactivation of OFC by infusions of the GABA(A) receptor agonist muscimol into area 13 blocked t

34 ects on the hippocampus by microinfusing the GABA(A) receptor agonist muscimol into the amygdala and

35 orary inactivation of the amygdala using the GABA(A) receptor agonist muscimol just before the onset

36 profound effects of the exogenously applied GABA(A) receptor agonist muscimol or glycine, either of

37 Furthermore, the GABA(A) receptor agonist muscimol produced a dose-depend

38 ng blockade of the contralateral BotC by the GABA(A) receptor agonist muscimol significantly reduced

39 lamic nucleus (DMH) by microinjection of the GABA(A) receptor agonist muscimol suppresses cardiovascu

40 nto the PnO of saline (vehicle control), the GABA(A) receptor agonist muscimol, muscimol with the GAB

41 closer glybenclamide, 4) diazoxide plus the GABA(A) receptor agonist muscimol, or 5) glybenclamide p

42 ion of the medial prefrontal cortex with the GABA(A) receptor agonist muscimol, which eliminates the

43 Inhibition of RTN neurons with the GABA(A) receptor agonist muscimol, with simultaneous dia

44 Bath application of GABA(A) receptor agonists muscimol (250 microM) or pento

45 n affibody plus a gamma-aminobutyric acid A (GABA(A)) receptor agonist muscimol, prior to a hypoglyce

46 Effects of spinal administration of the GABA(A)-receptor agonist muscimol (0.1-30 microg/50 micr

47 Injection of the GABA(A)-receptor agonist muscimol, but not naloxone, int

48 we characterized the in vitro effects of the GABAA receptor agonist muscimol (0.5, 0.25, 0.1 and 0.06

49 in explants cultured in the presence of the GABAA receptor agonist muscimol (10(-4) M).

50 TS) with glycine (40 nmol/80 nl) or with the GABAA receptor agonist muscimol (160 pmol/80 nl; 77 +/-

51 The GABAA receptor agonist muscimol also induced oxytocin re

52 ns into specific parietal circuits using the GABAA receptor agonist muscimol and validated the lesion

53 e same region by local microinjection of the GABAA receptor agonist muscimol can virtually abolish st

54 ivity in RA by intracerebral infusion of the GABAA receptor agonist muscimol decreased the number of

55 Whereas the GABAA receptor agonist muscimol evoked excitatory, inhib

56 Bilateral microinjection of the GABAA receptor agonist muscimol into the caudal ventrola

57 gm, we examined the effects of injecting the GABAA receptor agonist muscimol or the GABAA receptor an

58 cells in the AcbSh via administration of the GABAA receptor agonist muscimol or the GABAB receptor ag

59 a-aminobutyric acid (GABA), the GABA type a (GABAa) receptor agonist muscimol, and the GABAa receptor

60 Unilateral microinjection of a GABA(A) receptor agonist (muscimol, 200 pmol) into STN p

61 xperiment 1 examined whether infusion of the GABA(A) receptor agonist, muscimol (0.0, 4.4, 8.8 nmol),

62 (RVLM) with bilateral microinjections of the GABA(A) receptor agonist, muscimol (6 mM, 50 nl) which m

63 nown to modulate the specific binding of the GABA(A) receptor agonist, muscimol, in certain brain reg

64 g 0.2 microl of 1 mM or 10 mM solutions of a GABA(A) receptor agonist, muscimol, into the MnPN on Fos

65 The GABAA receptor agonist, muscimol (0.3-30 pmol), microinj

66 Conversely, microinfusions of the GABAA receptor agonist, muscimol (10, 25 and 50 pmol), i

67 Our results also demonstrated that the GABAA receptor agonist, muscimol, enhances pulsatile GnR

68 Either isoguvacine (a GABA(A) receptor agonist) or kynurenic acid (a non-selec

69 ed ataxia when administered the nonselective GABA(A) receptor agonists pentobarbital and pregnanolone

70 e studied the influence of lorazepam (LZ) (a GABA(A) receptor agonist) relative to that of dextrometh

71 At 4 degrees C, muscimol, a GABAA receptor agonist, stimulated 36Cl- efflux with an

72 ief applications of the weakly desensitizing GABA(A) receptor agonists taurine and beta-alanine.

73 THIP, a GABA(A) receptor agonist that preferentially activates d

74 tors declines in cortical neurons exposed to GABAA receptor agonists, the mechanisms responsible for

75 Application of the delta subunit GABAA receptor agonist THIP resulted in a tonic GABAA re

76 ist bicuculline or a selective extrasynaptic GABAA receptor agonist THIP, were significantly reduced

77 Administration of muscimol (GABA(A) receptor agonist) to the APC immediately suppres

78 er an intra-amygdala infusion of muscimol, a GABA(A) receptor agonist, to inactivate BLA neurons or a

79 ed to characterize the effect of muscimol, a GABAA receptor agonist, to enhance pulsatile gonadotropi

80 ergic 5-HT(3), or gamma-aminobutyric acid A (GABA(A)) receptor agonists were unaffected by brilliant